Zymeworks Inc.
ZYME
$12.25
-$0.30-2.39%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 0.38% | -86.52% | -85.99% | -88.69% | -81.57% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.38% | -86.52% | -85.99% | -88.69% | -81.57% |
| Cost of Revenue | -5.25% | -27.54% | -31.38% | -31.99% | -31.49% |
| Gross Profit | 11.66% | -121.05% | -120.96% | -131.28% | -132.74% |
| SG&A Expenses | -12.69% | -31.16% | -26.70% | -13.21% | -6.01% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -7.71% | -28.77% | -29.83% | -26.46% | -24.75% |
| Operating Income | 12.19% | -159.59% | -164.53% | -185.15% | -206.33% |
| Income Before Tax | 2.21% | -153.55% | -157.96% | -169.12% | -188.17% |
| Income Tax Expenses | 1,171.13% | -128.72% | -124.74% | -115.24% | -105.21% |
| Earnings from Continuing Operations | -3.39% | -155.38% | -160.46% | -172.98% | -195.44% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.39% | -155.38% | -160.46% | -172.98% | -195.44% |
| EBIT | 12.19% | -159.59% | -164.53% | -185.15% | -206.33% |
| EBITDA | 12.00% | -153.20% | -157.25% | -176.55% | -193.23% |
| EPS Basic | 6.95% | -148.23% | -154.13% | -168.88% | -197.80% |
| Normalized Basic EPS | 23.87% | -140.37% | -144.86% | -165.70% | -190.24% |
| EPS Diluted | 7.23% | -148.57% | -154.57% | -169.40% | -198.84% |
| Normalized Diluted EPS | 23.90% | -140.41% | -144.91% | -165.79% | -190.41% |
| Average Basic Shares Outstanding | 10.16% | 10.50% | 10.11% | 7.07% | 5.65% |
| Average Diluted Shares Outstanding | 10.20% | 10.50% | 10.10% | 7.06% | 5.62% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
